| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001510 | Rna methylation | Affects phenotype | PMID:37061066 |
| GO:0002280 | Monocyte activation involved in immune response | Increases phenotype | PMID:29540657 |
| GO:0002532 | Production of molecular mediator involved in inflammatory response | Increases phenotype | PMID:35499276 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:24112957 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:24112957; PMID:28296042 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:23317420 |
| GO:0006306 | Dna methylation | Increases phenotype | PMID:25957741 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:34612572 |
| GO:0006527 | Arginine catabolic process | Increases phenotype | PMID:23415871 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:10484457; PMID:34612572 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:23463385 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:28296042; PMID:35499276 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:35499276 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:31734292 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:12781210; PMID:23568779; PMID:24962574; PMID:25290854; PMID:37061066 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:34612572 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:22714537 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:29540657 |
| GO:0014068 | Positive regulation of phosphatidylinositol 3-kinase signaling | Decreases phenotype | PMID:23317420 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:26607348 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:21697260; PMID:22683935; PMID:27196738 |
| GO:0030001 | Metal ion transport | Increases phenotype | PMID:34612572 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:34612572 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:35499276 |
| GO:0032631 | Interleukin-27 production | Increases phenotype | PMID:30421605 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:23126276 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:23317420; PMID:34612572 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:29567110 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:23546878 |
| GO:0042307 | Positive regulation of protein import into nucleus | Decreases phenotype | PMID:25957741 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:23317420; PMID:39515573 |
| GO:0043553 | Negative regulation of phosphatidylinositol 3-kinase activity | Increases phenotype | PMID:34612572 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:23415871 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:35499276 |
| GO:0050671 | Positive regulation of lymphocyte proliferation | Increases phenotype | PMID:20677212 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:39515573 |
| GO:0050902 | Leukocyte adhesive activation | Increases phenotype | PMID:23126276 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Decreases phenotype | PMID:23317420 |
| GO:0051898 | Negative regulation of protein kinase b signaling | Increases phenotype | PMID:34612572 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:29567110; PMID:31734292 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24412756 |
| GO:0097029 | Mature conventional dendritic cell differentiation | Increases phenotype | PMID:25673294 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:39515573 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:23526216; PMID:25957741 |
| GO:1901224 | Positive regulation of nik/nf-kappab signaling | Increases phenotype | PMID:25957741 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:23317420; PMID:34612572 |
| GO:1903238 | Positive regulation of leukocyte tethering or rolling | Increases phenotype | PMID:23126276 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Decreases phenotype | PMID:23317420 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28296042; PMID:29567110 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:23317420; PMID:34612572; PMID:39515573 |
| GO:1905589 | Positive regulation of l-arginine import across plasma membrane | Affects phenotype | PMID:23415871 |
| GO:2000481 | Positive regulation of camp-dependent protein kinase activity | Increases phenotype | PMID:23126276 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.